Summary
M2 EQUITYBITES-December 21, 2011-UCB starts EXXELERATE clinical study for RA
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Ucb Starts Exxelerate Clinical Study for Ra
Global biopharmaceutical company UCB (Euronext: UCB) (Brussels: U...
See the full content of this document
Sponsored links
